Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.65 is 91% above its 5-year average of -6.89, near the high end of its 5-year range (-14.84–-0.23).
58.86% above its 12-month average of -1.58.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.12.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.65
EARNINGS PER SHARE (EPS) AVG TTM
-1.58
EARNINGS PER SHARE (EPS) AVG 3Y
-4.60
EARNINGS PER SHARE (EPS) AVG 5Y
-6.89
EARNINGS PER SHARE (EPS) AVG 10Y
-222.48
EARNINGS PER SHARE (EPS) AVG 15Y
-407.51
EARNINGS PER SHARE (EPS) AVG 20Y
-367.68
CURRENT VS TTM AVG
+58.86%
CURRENT VS 3Y AVG
+85.87%
CURRENT VS 5Y AVG
+90.57%
CURRENT VS 10Y AVG
+99.71%
CURRENT VS 15Y AVG
+99.84%
CURRENT VS 20Y AVG
+99.82%
Precipio, Inc.
Market Cap
$41.95M
Earnings Per Share (EPS)
-0.65
TTM Avg
-1.58
3Y Avg
-4.60
5Y Avg
-6.89
Market Cap
$42.46M
Earnings Per Share (EPS)
-1.68
TTM Avg
0.78
3Y Avg
0.08
5Y Avg
-0.02
Market Cap
$42.83M
Earnings Per Share (EPS)
-1.70
TTM Avg
-1.03
3Y Avg
-1.29
5Y Avg
-1.28
Market Cap
$40.53M
Earnings Per Share (EPS)
-0.87
TTM Avg
-1.21
3Y Avg
-1.66
5Y Avg
-1.49
Market Cap
$43.52M
Earnings Per Share (EPS)
-1.98
TTM Avg
-2.34
3Y Avg
-2.17
5Y Avg
-1.92
Market Cap
$43.60M
Earnings Per Share (EPS)
-1.11
TTM Avg
-1.06
3Y Avg
-1.20
5Y Avg
-1.30
Market Cap
$39.56M
Earnings Per Share (EPS)
-0.60
TTM Avg
-2.17
3Y Avg
-6.45
5Y Avg
-4.61
Market Cap
$39.15M
Earnings Per Share (EPS)
-2.49
TTM Avg
-2.22
3Y Avg
-1.86
5Y Avg
-2.21
Market Cap
$45.07M
Earnings Per Share (EPS)
-0.73
TTM Avg
-1.48
3Y Avg
-1.47
5Y Avg
-1.37
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Precipio, Inc. (PRPO) | $41.95M | -0.65 | -1.58 | -4.60 | -6.89 |
| BioStem Technologies, Inc. (BSEM)vs › | $42.46M | -1.68 | 0.78 | 0.08 | -0.02 |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.83M | -1.70 | -1.03 | -1.29 | -1.28 |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.53M | -0.87 | -1.21 | -1.66 | -1.49 |
| CVRx, Inc. (CVRX)vs › | $43.52M | -1.98 | -2.34 | -2.17 | -1.92 |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $43.60M | -1.11 | -1.06 | -1.20 | -1.30 |
| Veru Inc. (VERU)vs › | $39.56M | -0.60 | -2.17 | -6.45 | -4.61 |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.15M | -2.49 | -2.22 | -1.86 | -2.21 |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.07M | -0.73 | -1.48 | -1.47 | -1.37 |
| SANUWAVE Health Inc. (SNWV)vs › | $45.02M | 0.90 | -2.83 | -6.22 | -12.54 |
Trailing EPS (TTM)
$-0.65
Forward EPS (Est.)
$27.40
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.23 |
| 2024-12-31 | -2.93 |
| 2023-12-31 | -4.51 |
| 2022-12-31 | -10.73 |
| 2021-12-31 | -8.10 |
| 2020-12-31 | -14.84 |
| 2019-12-31 | -46.51 |
| 2018-12-31 | -217.81 |
| 2017-12-31 | -1338.20 |
| 2016-12-31 | -580.93 |
| 2014-12-31 | -837.26 |
| 2013-12-31 | -990.09 |
| 2012-12-31 | -646.66 |
| 2011-12-31 | -1070.24 |
| 2010-12-31 | -343.68 |
| 2009-12-31 | -210.78 |
| 2008-12-31 | -54.34 |
| 2007-12-31 | -231.31 |
| 2006-12-31 | -376.70 |
| 2005-12-31 | -2268.92 |
| 2003-12-31 | -5063.52 |
| 2002-12-31 | -4892.37 |
| 2001-12-31 | -1771.85 |
| 2000-12-31 | -2812.93 |
| 1999-12-31 | -4082.63 |
